Home
Clinical Resources Search
PQI: Glofitamab-gxbm (COLUMVI®) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Glofitamab-gxbm (COLUMVI®) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Download PQI pdf

Last Updated: December 19, 2024

By: Matthew Lei, PharmD, BCOP | J. Erika Haydu, MD, PhD

About this PQI

The purpose of this PQI is to review clinical considerations around the use of glofitamab-gxbm in the treatment of relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from follicular lymphoma.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Glofitamab-gxbm (COLUMVI®) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Implementing Reflex BRAF Testing in Metastatic Colorectal Cancer

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

S10 E13: Oncology Unfiltered: AI and the Future of Cancer Care

S10 E12: Inside GU Oncology with Uromigos Co-Host

S10 E10: Clearing the Fog: A Clinical Look at Chemo Brain

S10 E11: Your Best Meeting Ever

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Epcoritamab and GemOx

Glofitamab and GemOx

Rituximab, Cyclophosphamide, Vincristine and Prednisone

Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone

Glofitamab and GemOx

Glofitamab

Up Close with Glofitamab

Bispecific T-Cell Engagers in Non-Hodgkin Lymphoma: Treatment Discussion Guide

Glofitamab and GemOx

Glofitamab

Up Close with Glofitamab

Bispecific T-Cell Engagers in Non-Hodgkin Lymphoma: Treatment Discussion Guide

PQI: Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia

Gilteritinib

PQI in Action: Putting Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia (AML) into Action

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

Cyclophosphamide, Bortezomib, and Dexamethasone

Sirolimus

Tacrolimus